Characterization of anti-CD3 antibodies in clinically available bispecific T cell engagers.
Sign Up to like & getrecommendations! Published in 2025 at "Seminars in hematology"
DOI: 10.1053/j.seminhematol.2025.08.004
Abstract: Bispecific T cell engagers (bispecific TCEs) are engineered antibodies that redirect T cells to mediate tumor cell killing by simultaneously binding to CD3 on T cells and tumor-associated antigens. As of July 2025, ten bispecific… read more here.
Keywords: family; cd3; bispecific cell; bispecific tces ... See more keywords